Reasons for ineligibility
| . | N (%) . |
|---|---|
| Disease progression | 42 (34) |
| Poor health | 18 (15) |
| Opted for a research study | 14 (11) |
| Insurance | 12 (10)∗ |
| Underwent stem cell transplant | 8 (6) |
| Patient declined CART | 7 (6) |
| Remission/stability | 5 (4) |
| Manufacturing failure | 4 (3) |
| Alternate treatment center | 3 (2) |
| Unspecified/unknown | 11 (9) |
| . | N (%) . |
|---|---|
| Disease progression | 42 (34) |
| Poor health | 18 (15) |
| Opted for a research study | 14 (11) |
| Insurance | 12 (10)∗ |
| Underwent stem cell transplant | 8 (6) |
| Patient declined CART | 7 (6) |
| Remission/stability | 5 (4) |
| Manufacturing failure | 4 (3) |
| Alternate treatment center | 3 (2) |
| Unspecified/unknown | 11 (9) |
Insurance denials included ineligible without reason available (n = 6), previous CART (n = 2), transfer to another center (n = 2), central nervous system disease (n = 1), and had not failed second-line therapy (n = 1).